Over 71% of the top ZK holders sold their tokens post-airdrop
The airdrop for zkSync native tokens happened 30 hours ago and over 71% of the top 10,000 addresses sold their tokens completely or partially, according to a dashboard by on-chain data firm Nansen.
Image: Nansen
The dashboard calls the sellers by the slang “jeeters,” and 4,113 addresses jeeted their entire holdings in the last 30 hours, totaling over 347 million ZK tokens. The partial jeeters sold significantly less, as 3,033 wallets dumped nearly 150 million tokens on the market.
The number of the top 10,000 addresses by rewards received that chose to believe in the token equals 2,854, which is 28.5% of all users that got ZK.
Some investors shared on X that it made sense to hold ZK, as its fully diluted value (FDV) came out below fellow Ethereum layer-2 blockchains, such as Starknet. FDV is a metric used to measure if a token is under or overvalued based on its peers. At the time of writing, ZK price sits at $0.20, and its fully diluted value is at $4.2 billion.
According to a report by data aggregator CoinGecko, ZK holders have a substantial chance to see price growth in the next few days, as 46% of the 50 biggest airdrops took two weeks to reach their all-time highs. Of the 23 tokens in this group, 16 of them took two to 14 days to reach their price peak.
Although this historical pattern doesn’t guarantee profits, some investors might be willing to wait and see how the ZK token will repeat history in the next 13 days.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
"Predicting Your Prediction" Intensifies Tech Stock Sell-off! After $2.3 Trillion Market Value Evaporates, Has the "Hot Money" Mechanical Selling Still Not Subsided?
The Nasdaq 100 Index fell by 6.4%, wiping out $2.3 trillion in market capitalization. The core reason behind this decline is concerns that a comprehensive victory by the Democratic Party could lead to stricter regulations on AI development. Systematic funds, which typically follow the stock market's trend and respond to price fluctuations and momentum signals, were thus forced to reduce their investments, accelerating the downturn. The selling pressure from systematic strategies may not be over yet; it is expected that in the coming days, portfolios targeting volatility will sell at least $50 billion worth of stocks.
Crypto prices
More
